DMT and Ayahuasca Student Educational Slides

Ayahuasca has been used as a medicine in Mesoamerican ceremonies for thousands of years, but the primary psychoactive compound, DMT, was not synthesised until 1931. DMT was studied during the wave of psychedelic research in the 1950s and 60s until research was banned in 1971 by the Convention of Psychotropic Substances. Ayahuasca was not included  …


Ending the pain of children with severe epilepsy?

An audit of the impact of medical cannabis in 10 patients with severe epilepsy. Background Scientific and anecdotal evidence suggest that whole-plant cannabis extracts are effective in reducing seizure frequency in individuals with a range of epileptic etiologies. We report a case series of 10 individuals using CBMPs in the UK to treat their conditions.  …


2019: A year of expansion in psychedelic research, industry, and deregulation

Public and scientific interest into psychedelic drugs has grown steadily over much of the last two decades, before an exponential increase in recent years. We contend that 2019, in particular, involved myriad notable changes in the science, industry, and deregulation of psychedelic drugs. However, it is becoming increasingly difficult for professionals to keep up-to-date on  …


#21 - Drugs and consciousness

In this episode of the Drug Science podcast, Professor Nutt is joined by an old friend who he has known for 35 years. Professor Roland Griffiths is a researcher who has examined a wide range of psychotropic substances over the years. He has studied, the abuse potential of a number of different substances; caffeine dependence  …


Principled sentencing for drug supply offences: Revised methamphetamine sentencing guidelines in New Zealand

Methamphetamine was reclassified as a Class A drug in New Zealand in 2003. This meant harsher sentences for people convicted of its manufacture, importation or supply. Despite this, the number of convictions for methamphetamine-related offending continued to increase. In 2019, the New Zealand Court of Appeal agreed to review the sentencing of people convicted of  …


#19 - DMT

  DMT is a drug that’s relatively novel in western neuropsychopharmacology. Not much research has been done on this substance to date and many intoxicants are unable to recount their psychedelic experience. For the first time, this substance is being studied in an fMRI and EEG to elucidate why and how this drug elucidates vivid  …


Percentages of problem drug use and their implications for policy making: A review of the literature

This paper reviews the literature on problem drug use, aiming to answer the question ‘what percentages of drug users are problem drug users?’ We look at the conceptualisation of problem drug use, and related concepts such as addiction and dependence. While conceptually distinct, definitions vary, and terms are often utilised interchangeably in the literature. Because  …